487 related articles for article (PubMed ID: 23249332)
1. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
Giddam AK; Zaman M; Skwarczynski M; Toth I
Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
[TBL] [Abstract][Full Text] [Related]
2. Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.
Korsholm KS; Andersen PL; Christensen D
Expert Rev Vaccines; 2012 May; 11(5):561-77. PubMed ID: 22827242
[TBL] [Abstract][Full Text] [Related]
3. Liposomal vaccine delivery systems.
Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
[TBL] [Abstract][Full Text] [Related]
4. Liposomes as delivery systems for nasal vaccination: strategies and outcomes.
Heurtault B; Frisch B; Pons F
Expert Opin Drug Deliv; 2010 Jul; 7(7):829-44. PubMed ID: 20459361
[TBL] [Abstract][Full Text] [Related]
5. Cationic liposomes as vaccine adjuvants.
Christensen D; Korsholm KS; Andersen P; Agger EM
Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting microencapsulation of drugs in liposomes.
Kulkarni SB; Betageri GV; Singh M
J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
8. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
9. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
[TBL] [Abstract][Full Text] [Related]
10. Topical and mucosal liposomes for vaccine delivery.
Romero EL; Morilla MJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):356-75. PubMed ID: 21360692
[TBL] [Abstract][Full Text] [Related]
11. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
12. [Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
Budai M; Szógyi M
Acta Pharm Hung; 2001; 71(1):114-8. PubMed ID: 11769091
[TBL] [Abstract][Full Text] [Related]
13. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.
Gregoriadis G; Florence AT
Drugs; 1993 Jan; 45(1):15-28. PubMed ID: 7680982
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units.
Jain B; Singh B; Katare OP; Vyas SP
J Liposome Res; 2010 Jun; 20(2):105-14. PubMed ID: 19698000
[TBL] [Abstract][Full Text] [Related]
15. Trends and developments in liposome drug delivery systems.
Lian T; Ho RJ
J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
[TBL] [Abstract][Full Text] [Related]
16. Liposomal drug formulations in the treatment of rheumatoid arthritis.
van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G
Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436
[TBL] [Abstract][Full Text] [Related]
17. Liposomes as biocompatible and smart delivery systems - the current state.
Dymek M; Sikora E
Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
[TBL] [Abstract][Full Text] [Related]
18. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
19. Engineering liposomes for drug delivery: progress and problems.
Gregoriadis G
Trends Biotechnol; 1995 Dec; 13(12):527-37. PubMed ID: 8595139
[TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
